The case, docketed on January 8, 2026, as Case No. 2:26-cv-01542, pulls in three insulin manufacturers — Eli Lilly and Company, Novo Nordisk Inc., and Sanofi-Aventis U.S. LLC – alongside the pharmacy benefit management operations of Cigna Health Read More
